Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KalVista Pharmaceuticals (KALV) Short term Debt (2016)

Historic Short term Debt for KalVista Pharmaceuticals (KALV) over the last 3 years, with Q1 2016 value amounting to $2.0 million.

  • KalVista Pharmaceuticals' Short term Debt rose 8139.53% to $2.0 million in Q1 2016 from the same period last year, while for Mar 2016 it was $2.0 million, marking a year-over-year increase of 8139.53%. This contributed to the annual value of $127000.0 for FY2016, which is N/A changed from last year.
  • According to the latest figures from Q1 2016, KalVista Pharmaceuticals' Short term Debt is $2.0 million, which was up 8139.53% from $1.5 million recorded in Q4 2015.
  • KalVista Pharmaceuticals' Short term Debt's 5-year high stood at $4.4 million during Q4 2014, with a 5-year trough of $480000.0 in Q2 2015.
  • Moreover, its 3-year median value for Short term Debt was $1.3 million (2015), whereas its average is $1.7 million.
  • In the last 5 years, KalVista Pharmaceuticals' Short term Debt plummeted by 6719.28% in 2015 and then skyrocketed by 8139.53% in 2016.
  • KalVista Pharmaceuticals' Short term Debt (Quarter) stood at $4.4 million in 2014, then plummeted by 67.19% to $1.5 million in 2015, then surged by 34.02% to $2.0 million in 2016.
  • Its Short term Debt stands at $2.0 million for Q1 2016, versus $1.5 million for Q4 2015 and $965000.0 for Q3 2015.